Vitasora HealthASX:VHL Current Ratio is 2.95 as of Dec. 2025, which is 20% above its 10-year median of 2.45. The stock has 6 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Vitasora Health ranks better than 76.36% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Vitasora Health's current ratio for the quarter that ended in Dec. 2025 was 2.95.
Vitasora Health has a current ratio of 2.95. It generally indicates good short-term financial strength.
The historical rank and industry rank for Vitasora Health's Current Ratio or its related term are showing as below:
ASX:VHL'
s Current Ratio Range Over the Past 10 Years
Min: 0.39 Med: 2.45 Max: 10.93
Current: 2.95
During the past 13 years, Vitasora Health's highest Current Ratio was 10.93. The lowest was 0.39. And the median was 2.45.
ASX:VHL's Current Ratio is ranked better than 76.36% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.48
vs ASX:VHL: 2.95
Vitasora Health (ASX:VHL) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Vitasora Health Current Ratio Related Terms
Vitasora Health Current Ratio Historical Data
* Premium members only.
The historical data trend for Vitasora Health's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:VHL vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, Vitasora Health's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitasora Health Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vitasora Health's Current Ratio distribution charts can be found below:
* The bar in red indicates where Vitasora Health's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitasora Health (ASX:VHL) has a Current Ratio of 2.95 as of Dec. 2025. This is 20% above median its historical median of 2.45. Over the past decade, Vitasora Health's Current Ratio has ranged from 0.39 to 10.93. According to the industry distribution chart, Vitasora Health ranks #161 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 23.6%.
Is Vitasora Health's Current Ratio too high?
Vitasora Health's current Current Ratio of 2.95 is 20% above median its 10-year median of 2.45. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 10.93. The Healthcare Providers & Services industry median Current Ratio is 1.48. Vitasora Health's value of 2.95 is 99.3% above this industry median. Based on the distribution chart, Vitasora Health ranks #161 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Vitasora Health's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitasora Health ranks #161 out of 681 companies for Current Ratio. This places Vitasora Health in the top 24% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.48. Vitasora Health's value of 2.95 is 99.3% above this benchmark. Historically, Vitasora Health's own Current Ratio has ranged from 0.39 to 10.93 over the past decade. While the company's 10-year median is 2.45 vs. the industry median of 1.48, Vitasora Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.48, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitasora Health's current Current Ratio of 2.95 is 99.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitasora Health's current Current Ratio is 2.95, which is 20% above median its own 10-year median of 2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitasora Health stock overvalued right now?
Vitasora Health (ASX:VHL) has a current Current Ratio of 2.95. The current Current Ratio is 2.95, which is 20% above median its 10-year median of 2.45 and 99.3% above the Healthcare Providers & Services industry median of 1.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Vitasora Health (ASX:VHL), the current Current Ratio is 2.95 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VHL has been successfully added to your 